ABMC - American Bio Medica Corporation

Other OTC - Other OTC Delayed Price. Currency in USD
0.0700
0.0000 (0.00%)
As of 9:49AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close 0.0700
Open 0.0700
Bid 0.0000 x 0
Ask 0.0000 x 0
Day's Range 0.0700 - 0.0700
52 Week Range 0.0400 - 0.1300
Volume 10,000
Avg. Volume 1,382
Market Cap 2.278M
Beta (3Y Monthly) 0.82
PE Ratio (TTM) N/A
EPS (TTM) -0.0290
Earnings Date Nov 11, 2019 - Nov 15, 2019
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A
Trade prices are not sourced from all markets
  • ACCESSWIRE

    ABMC Reports Second Quarter 2019 Results

    KINDERHOOK, NY / ACCESSWIRE / August 14, 2019 / American Bio Medica Corporation ( OTC PINK:ABMC ) today announced financial results for the three and six months ended June 30, 2019. Chief Executive Officer ...

  • ACCESSWIRE

    ABMC Oral Fluid Consent Decree Vacated

    KINDERHOOK, NY / ACCESSWIRE / May 24, 2019 / American Bio Medica Corporation (ABMC) announced today that on May 23, 2019, its Consent Decree of Permanent Injunction (Consent Decree) with the U.S. Food and Drug Administration (FDA) has been vacated and the case has been closed. This action resolves a long-standing inability of the Company to market and sell oral fluid drug tests in the employment market.

  • ACCESSWIRE

    ABMC Reports First Quarter 2019 Results

    KINDERHOOK, NY / ACCESSWIRE / May 20, 2019 / American Bio Medica Corporation (OTC PINK: ABMC) today announced financial results for the three months ended March 31, 2019. Chief Executive Officer Melissa ...

  • ACCESSWIRE

    ABMC Reports Fourth Quarter And Year End 2018 Results

    KINDERHOOK, NY / ACCESSWIRE / April 16, 2019 / American Bio Medica Corporation (OTC PINK: ABMC) today announced financial results for the fourth quarter and year ended December 31, 2018. Chief Executive ...

  • ACCESSWIRE

    ABMC Reports Third Quarter 2018 Results

    KINDERHOOK, NY / ACCESSWIRE / November 13, 2018 / American Bio Medica Corporation (OTC PINK: ABMC) today announced financial results for the three and nine months ended September 30, 2018. Chief Executive ...